October 23, 2014 4:07 AM ET

Pharmaceuticals

Company Overview of Biosynexus Incorporated

Company Overview

Biosynexus Incorporated, a biopharmaceutical company, develops and commercializes pharmaceutical products for the prevention and treatment of multidrug resistant staphylococcal infections in infants. Its products include Pagibaximab, an anti-lipoteichoic acid monoclonal antibody for use in preventing staphylococcal infections in neonates; lysostaphin, a bacterial enzyme that destroys chemical links in the cell walls of staphylococci; and nisin, a topical antibiotic cream used for treatment of skin infections. The company has a strategic collaboration with GSK Biologicals. Biosynexus Incorporated was founded in 1999 and is based in Gaithersburg, Maryland.

9298 Gaither Road

Gaithersburg, MD 20877-1440

United States

Founded in 1999

Phone:

301-330-5800

Fax:

301-944-2141

Key Executives for Biosynexus Incorporated

Chief Executive Officer
Age: 64
Controller
Director of Clinical Operations
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Baxter Pharmaceutical Products, Inc. United States
Moleculin, L.L.C. United States
Luitpold Pharmaceuticals, Inc. United States
Maret Corporation United States
Nautilus Neurosciences, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Biosynexus Incorporated, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.